Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

NCT05086731

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, +27 more
Locations
  • Grady Memorial Hospital Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details
Completed

A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands

NCT01351103

Conditions
BRAF Mutant Colorectal Cancer, Breast Diseases, Breast Neoplasms, +35 more
Locations
  • UCLA School of Medicine Los Angeles, California, United States
  • Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Onc Dept. Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

NCT01349959

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery

NCT00576654

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +12 more
Locations
  • Yale University New Haven, Connecticut, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions